Could stem cell exosomes help stroke patients recover?

NCT ID NCT06138210

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial tests whether exosomes from stem cells can help people recover from a recent stroke. 29 participants will receive either the exosome treatment or a placebo, and researchers will check for safety and any signs of improved function. The study is small and exploratory, so the main goal is to see if the approach is safe enough to test further.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
exosomes from human induced pluripotent stem cells (GD-iExo-003)
What this could lead to
If it works, this could point toward a new treatment to improve recovery and reduce disability after a stroke.
What could go wrong
This is a very early, small study (29 people) focused mainly on safety, not proof of effectiveness. The treatment may not work better than placebo, and side effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Xuanwu Hospital, Capital Medical University

    RECRUITING

    Beijing, 100053, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.